Cognizant Forecast, price target & analysts
Cognizant Target price 2025 - Analyst rating & recommendation
Cognizant Classifications & Recommendation:
Cognizant Price Target
| Target Price | $89.47 |
| Price | $76.42 |
| Potential | 17.08% |
| Number of Estimates | 19 |
| 19 Analysts have issued a price target Cognizant 2026 . The average Cognizant target price is $89.47. This is 17.08% higher than the current stock price. The highest price target is $103.00 34.78% , the lowest is $80.00 4.68% . | |
| A rating was issued by 29 analysts: 5 Analysts recommend Cognizant to buy, 21 to hold and 3 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Cognizant stock has an average upside potential 2026 of 17.08% . Most analysts recommend the Cognizant stock at Hold. |
Sales and Margin forecast 2025, 2026 to 2028
22 Analysts have issued a sales forecast Cognizant 2025 . The average Cognizant sales estimate is $20.7b . This is 4.69% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $21.0b 6.53% , the lowest is $20.5b 3.99% .
This results in the following potential growth metrics:
Revenue Estimates
| 2024 | $19.7b | 1.98% |
|---|---|---|
| 2025 | $20.7b | 4.69% |
| 2026 | $21.7b | 5.14% |
| 2027 | $23.3b | 7.38% |
| 2028 | $24.2b | 3.63% |
15 Analysts have issued an Cognizant EBITDA forecast 2025. The average Cognizant EBITDA estimate is $3.8b . This is 7.10% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $4.1b 16.54% , the lowest is $3.7b 4.32% .
This results in the following potential growth metrics and future EBITDA Margins:
EBITDA Estimates
| 2024 | $3.5b | 2.31% |
|---|---|---|
| 2025 | $3.8b | 7.44% |
| 2026 | $4.0b | 4.87% |
| 2027 | $4.4b | 9.57% |
EBITDA Margin
| 2024 | 17.95% | 0.32% |
|---|---|---|
| 2025 | 18.42% | 2.61% |
| 2026 | 18.38% | 0.22% |
| 2027 | 18.75% | 2.01% |
12 Cognizant Analysts have issued a net profit forecast 2025. The average Cognizant net profit estimate is $2.5b . This is 10.59% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $2.5b 12.20% , the lowest is $2.4b 8.65% .
This results in the following potential growth metrics and future Net Margins:
Net Profit Estimates
| 2024 | $2.2b | 7.13% |
|---|---|---|
| 2025 | $2.5b | 10.59% |
| 2026 | $2.7b | 8.14% |
| 2027 | $2.9b | 9.33% |
| 2028 | $2.9b | 0.15% |
Net Margin
| 2024 | 11.31% | 5.05% |
|---|---|---|
| 2025 | 11.95% | 5.64% |
| 2026 | 12.29% | 2.85% |
| 2027 | 12.51% | 1.79% |
| 2028 | 12.09% | 3.36% |
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2028
12 Analysts have issued a Cognizant forecast for earnings per share. The average Cognizant EPS is $4.99 . This is 10.64% higher than earnings per share in the financial year 2024. The highest EPS forecast is $5.06 12.20% , the lowest is $4.90 8.65% .
This results in the following potential growth metrics and future valuations:
Earnings Per Share
| 2024 | $4.51 | 7.13% |
|---|---|---|
| 2025 | $4.99 | 10.64% |
| 2026 | $5.39 | 8.02% |
| 2027 | $5.90 | 9.46% |
| 2028 | $5.91 | 0.17% |
P/E ratio
| Current | 16.96 | 5.30% |
|---|---|---|
| 2025 | 15.32 | 9.67% |
| 2026 | 14.17 | 7.51% |
| 2027 | 12.96 | 8.54% |
| 2028 | 12.94 | 0.15% |
Based on analysts' sales estimates for 2025, the Cognizant stock is valued at an EV/Sales of 1.79 and an P/S ratio of 1.83 .
This results in the following potential growth metrics and future valuations:
EV/Sales
| Current | 1.88 | 0.53% |
|---|---|---|
| 2025 | 1.79 | 4.60% |
| 2026 | 1.71 | 4.88% |
| 2027 | 1.59 | 6.88% |
| 2028 | 1.53 | 3.51% |
P/S ratio
| Current | 1.92 | 1.17% |
|---|---|---|
| 2025 | 1.83 | 4.47% |
| 2026 | 1.74 | 4.89% |
| 2027 | 1.62 | 6.87% |
| 2028 | 1.56 | 3.51% |
Current Cognizant Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| UBS |
Neutral
➜
Neutral
|
Unchanged | Mar 17 2025 |
| Morgan Stanley |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Mar 12 2025 |
| Barclays |
Overweight
➜
Overweight
|
Unchanged | Feb 10 2025 |
| Needham |
Hold
➜
Hold
|
Unchanged | Feb 06 2025 |
| BMO Capital |
Market Perform
➜
Market Perform
|
Unchanged | Feb 06 2025 |
| RBC Capital |
Sector Perform
➜
Sector Perform
|
Unchanged | Feb 06 2025 |
| Morgan Stanley |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Feb 06 2025 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
UBS:
Neutral
➜
Neutral
|
Mar 17 2025 |
|
Unchanged
Morgan Stanley:
Equal-Weight
➜
Equal-Weight
|
Mar 12 2025 |
|
Unchanged
Barclays:
Overweight
➜
Overweight
|
Feb 10 2025 |
|
Unchanged
Needham:
Hold
➜
Hold
|
Feb 06 2025 |
|
Unchanged
BMO Capital:
Market Perform
➜
Market Perform
|
Feb 06 2025 |
|
Unchanged
RBC Capital:
Sector Perform
➜
Sector Perform
|
Feb 06 2025 |
|
Unchanged
Morgan Stanley:
Equal-Weight
➜
Equal-Weight
|
Feb 06 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
